SEMA3A and glioblastoma: TGF-βR1 knockdown significantly diminished both Sema3A-induced proliferation and clonogenic growth of GBM cells, suggesting that TGF-β pathway is a key downstream effector of the Sema3A/NRP1 signaling (Figure 5, A and B).